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Abstract
Background: There is an important global need to improve early detection of oral cancer. Recent reports suggest that 
optical imaging technologies can aid in the identification of neoplastic lesions in the oral cavity; however, there is little 
data evaluating the use of optical imaging modalities in resource limited settings where oral cancer impacts patients 
disproportionately. In this article, we evaluate a simple, low-cost optical imaging system that is designed for early 
detection of oral cancer in resource limited settings. We report results of a clinical study conducted at Tata Memorial 
Hospital (TMH) in Mumbai, India using this system as a tool to improve detection of oral cancer and its precursors.
Methods: Reflectance images with white light illumination and fluorescence images with 455 nm excitation were 
obtained from 261 sites in the oral cavity from 76 patients and 90 sites in the oral cavity from 33 normal volunteers. 
Quantitative image features were used to develop classification algorithms to identify neoplastic tissue, using clinical 
diagnosis of expert observers as the gold standard.
Results: Using the ratio of red to green autofluorescence, the algorithm identified tissues judged clinically to be cancer 
or clinically suspicious for neoplasia with a sensitivity of 90% and a specificity of 87%.
Conclusions: Results suggest that the performance of this simple, objective low-cost system has potential to improve 
oral screening efforts, especially in low-resource settings.
Background
Oral cancer is a major health problem worldwide, causing
over 127,000 deaths each year [1]. With an annual inci-
dence exceeding 274,000 cases, oral cancer ranks as one
of the top ten most common malignancies. Over two-
thirds of cases and three-quarters of deaths due to oral
cancer occur in developing countries [2]. In the U.S., the
overall five-year-survival rate for patients with oral can-
cer is only 54%, one of the lowest rates of all major can-
cers; in developing countries, five-year survival rates drop
below 30% [1,3]. Patients with early lesions have better
chances for cure and less treatment associated morbidity,
yet despite the easy accessibility of the mouth, most
patients present with advanced tumors, when treatment
is more difficult, more expensive and less successful com-
pared to earlier interventions. Early detection of oral pre-
malignant lesions (OPLs) and early neoplastic changes
may be our best and most cost-effective means to
improve survival and quality of life for oral cancer
patients from all socioeconomic communities [3].
No satisfactory mechanism exists currently to screen
and detect early neoplastic changes of the oral cavity in
the general population. Possible explanations include: 1)
There is limited public awareness and insufficient educa-
tion of health care workers about oral cancer risk factors,
signs and symptoms. 2) Detection relies heavily on clini-
cal experience at recognition of suspicious lesions during
physical examination, with variable effectiveness [4,5]. It
can be difficult to distinguish OPLs from more common
inflammatory conditions. 3) Practitioners and patients
are reluctant to perform invasive biopsies of oral lesions
which are expensive and often require referral to a spe-
cialist. 4) Some patients have field cancerization, where
the entire mucosal lining that is exposed to carcinogens
in alcohol and tobacco sustains damage and is at risk to
develop cancer [6]. In high risk patients, often the whole
lining of the oral cavity is potentially premalignant, mak-
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when and where to biopsy [5]. The situation is even more
challenging in developing countries and low-resource
regions with high-risk populations, where a combination
of lack of public awareness of the disease and inadequate
resources and expertise for screening can result in even
greater delays in diagnosis, leading to higher morbidity
and mortality. One recent study conducted in southern
India concluded that even simple visual examination by
health workers can prevent 37,000 oral cancer deaths
annually worldwide [7].
Recent advances in optical imaging have the potential
to improve early detection of oral cancer and its precur-
sors. Several groups have demonstrated that imaging sys-
tems that record the spatial distribution of tissue
fluorescence at specific excitation/emission wavelength
combinations can be used to survey large areas of oral
cavity mucosa to non-invasively detect early changes
associated with oral cancer in real-time [5,7-12]. Lane
presented a non-magnifying hand-held device for direct
visualization of oral cavity tissue fluorescence, which is
now FDA approved for clinical use and commercially
available as the VELscope® [5]. The system uses a metal-
halide lamp with emission peaks at 405 and 436 nm to
excite autofluorescence; images viewed by eye through
the VELscope indicate a characteristic loss of fluores-
cence associated with malignant progression. Results
from 50 biopsies taken from areas with loss of fluores-
cence in 44 patients showed a sensitivity of 98% and spec-
ificity of 100% for discriminating normal tissue from
severe dysplasia, carcinoma in situ, or invasive carci-
noma, using histology as the gold standard. An important
finding was the ability of fluorescence visualization to aid
clinicians in identifying early neoplastic lesions that were
initially missed during traditional white light examination
(WLE) [11].
To address the need for objective image interpretation,
Roblyer recently described a multimodal digital micro-
scope to obtain digital images of oral tissue fluorescence
and reflectance and evaluated the ability of objective
image analysis techniques to recognize OPLs and early
oral cancer. Using 405 nm excited fluorescence images,
algorithms could detect OPLs and oral cancer with a sen-
sitivity of 94% and specificity of 87% in 64 patients [12].
The results of automated analysis of digital autofluores-
cence images must also be validated in larger clinical tri-
als.
While digital image analysis can provide more objective
interpretation, lower cost devices are needed for use in
developing countries. To address the need for low-cost
imaging, Rahman recently developed a multi-modal
imaging system for screening and detection of oral cancer
in high-risk populations in low-resource and remote set-
tings [13]. This portable, battery powered system
acquires near real-time digital images of oral tissue in
reflectance and fluorescence mode. In this paper, we
report results of a clinical study to evaluate the ability of
this device to aid in detection of oral cancer in India
involving 109 subjects at high-risk for developing oral
cancer. We also characterize the optical properties of two
types of potentially confounding oral lesions, melanosis
and oral submucous fibrosis (OSF), which are common in
this region, and discuss how the presence of these lesions




The portable imaging system used in this study consisted
of a modified commercial headlamp system; details of the
device have been described previously [13]. Briefly, the
multi-modal imaging system uses light emitting diodes
(LEDs) to illuminate the oral mucosa. For fluorescence
imaging, the system has a blue LED with an excitation
peak at 455 nm wavelength; for reflectance imaging, it
has a white LED with an illumination range of 400 to 700
nm. Images can either be observed visually or captured
digitally through a set of optical filters using an inte-
grated, miniature charge coupled device (CCD) camera.
The system is connected to a laptop via a firewire inter-
face to record and store the images. The portable system
weighs only 3 pounds and can be powered by a lithium-
ion battery.
Protocol and Image Acquisition
The study was conducted at Tata Memorial Hospital
(TMH) in Mumbai, India. Patients who were referred to
the Cancer Prevention Clinic at Tata Memorial Hospital
because of suspicious oral lesions or were waiting for
head & neck surgery in the hospital ward were recruited
to participate in the study. In addition to patients, healthy
volunteers with and without a history of using tobacco
were recruited to participate in the study. The clinical
study was reviewed and approved by the Hospital Ethics
Committee (HEC) at TMH and the image analysis study
was reviewed and approved by the Institutional Review
Board at Rice University. Written informed consent was
obtained from each subject enrolled in the study.
In vivo imaging measurements from subjects were
obtained in the Cancer Prevention Clinic. All measure-
ments were taken in a darkened room to avoid room light
interference. The imaging system was positioned approx-
imately 20 cm away from the subjects. Reflectance image
exposure was a few milliseconds while fluorescence
image exposure was approximately 500 milliseconds.
A head & neck specialist at the clinic assessed each par-
ticipating patient by conducting a conventional examina-
tion of the oral cavity. Initial clinical impression of each
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presence of either melanosis - darkly pigmented lesions -
or oral submucous fibrosis - rigid, fibrotic white lesions -
was noted if visible. After clinical examination, digital
reflectance and fluorescence images were obtained from
clinically abnormal sites and contralateral clinically nor-
mal sites. Images were also obtained from the lateral bor-
der of the tongue, the buccal mucosa, and the lip of each
subject whenever these sites were accessible. A quality
control check was performed on all images before further
analysis. Sites with poor image quality (e.g. out-of-focus
images) were excluded from analysis.
For sites with an initial clinical impression of abnormal,
the white light reflectance images were reviewed by three
expert observers who were blinded to the fluorescence
images (NI, AG, PC). At each site, the observer assigned a
single clinical impression of 'Normal', 'Low Risk for Neo-
plasia', 'High Risk for Neoplasia', or 'Cancer'. Consensus
clinical impression was used to determine the final diag-
nostic category for each site imaged. In cases where the
impression of one of the expert observers differed from
the other two, the clinical impression assigned by two of
the three observers was used as the consensus. Measure-
ments in which all three observers disagreed on the clini-
cal impression were excluded from the analysis; a total of
four sites were excluded for this reason. Sites with an ini-
tial clinical impression of normal were categorized with a
diagnosis of 'Normal'. Performances of algorithms based
on features of digital optical image analysis are reported
relative to this consensus clinical impression.
Image Analysis
White light reflectance images of each site were first
examined; if the area was clinically abnormal, a region of
interest (ROI) corresponding to the lesion was defined. If
the area was clinically normal, a representative ROI was
selected from the white light reflectance image. The same
ROI was identified in each color fluorescence image of
that site, and quantitative image features were calculated
for each ROI.
Reflectance and fluorescence images were analyzed to
yield possible features for use in classification algorithms.
The following metrics were generated for ROIs corre-
sponding to lesions and contralateral normal measure-
ments: the average intensity in the red, green and blue
(RGB) channels, average values of the ratios of the R/G,
R/B and B/G intensities, the average intensity following
grayscale conversion, and the standard deviation of the
RGB and grayscale intensity values. In addition, for each
ROI corresponding to a clinically abnormal site, we calcu-
lated the ratio of the metric for the lesion relative to that
measured from the contralateral normal ROI in the same
patient. We refer to these metrics as 'normalized ratios'.
For measurements from clinically normal sites, normal-
ized ratios were obtained by dividing each ROI in two and
calculating the ratio of the metrics from the two resulting
regions.
We explored which of these features provided the best
separation between non-neoplastic oral mucosa and neo-
plastic oral mucosa. For calculation of sensitivity and
specificity, sites with a diagnosis of 'Cancer' or 'High Risk'
were considered to be neoplastic, while sites with a clini-
cal diagnosis of 'Normal' or 'Low Risk' were considered to
be non-neoplastic. Prior to feature selection, sites with a
clinical descriptor of melanosis were excluded from the
data set. Binary classification algorithms were developed
using linear discriminant analysis with a single image fea-
ture as input. The same clinical dataset was used to both
develop the algorithm and to assess classification accu-
racy. For each image feature, diagnostic performance was
assessed as the threshold was varied from the minimum
to the maximum of its value to generate a receiver operat-
ing characteristic (ROC) curve. Classification perfor-
mance measures, such as the area under the receiver
operating curve (AUC), sensitivity and specificity at the
Q-point, were calculated for each of the input metrics
using consensus clinical impression as the gold standard.
Results
Images from a total of 351 different sites were included in
the analysis (Table 1). 261 of these sites were imaged from
76 patients and 90 sites were imaged from 33 normal vol-
unteers. A total of 222 sites had a consensus clinical
impression of normal, 30 sites had a consensus clinical
impression of low risk for neoplasia, 22 sites had a con-
sensus clinical impression of high risk for neoplasia, and
37 had a consensus clinical impression of cancer. Melano-
sis was noted in 30 sites, and oral submucous fibrosis was
visible in ten sites.
Figure 1 shows typical white light reflectance and fluo-
rescence images of sites corresponding to each of the four
consensus clinical impression categories. Fluorescence
images of sites with a consensus clinical impression of
'Normal' showed homogenous green mucosal fluores-
cence. Sites with a consensus clinical impression of 'Low
Risk' or 'High Risk' exhibited a progressive loss of green
fluorescence, while sites with a consensus clinical impres-
sion of 'Cancer' typically showed both a loss of green fluo-
rescence and an increase in orange-red fluorescence.
Figure 2 shows white light reflectance and fluorescence
images of two potentially confounding lesions found in
the study population - oral submucous fibrosis (OSF) and
melanosis. In white light reflectance images, OSF sites
exhibited a pale white, patchy appearance similar to leu-
koplakia. However, unlike leukoplakia which is often
associated with decreased green fluorescence, no loss of
fluorescence was observed in sites with a clinical descrip-
tion of OSF. Melanosis sites were easily recognized from
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were consistently associated with decreased green fluo-
rescence.
Algorithms based on individual image features were
ranked according to the area under the ROC curve
(AUC); Table 2 lists the AUC for the five algorithms with
the best performance relative to consensus clinical
impression; all were based on normalized features of flu-
orescence images. The top three performing algorithms
were based on the normalized mean fluorescence inten-
sity (MFI) of the blue channel, the normalized MFI of the
green channel, and the normalized ratio of red to green
MFI. Linear discriminant analysis involving combinations
of image features did not significantly improve classifica-
tion performance.
Figure 3 shows scatter plots of the image features and
corresponding ROC curves for classification algorithms
which resulted in the best sensitivity and specificity,
respectively. Figure 3a shows the normalized MFI from
the blue channel by diagnostic category for all sites.
Those sites with a consensus clinical impression of 'Nor-
mal' and clinically visible melanosis or OSF are shown
separately. Sites with a consensus clinical impression of
'Low Risk', 'High Risk' or 'Cancer' exhibit decreased nor-
malized blue MFI compared to 'Normal' sites. Sites with
melanosis show decreased normalized blue MFI, while
those with OSF have similar normalized blue MFI to
other 'Normal' sites. Figure 3b shows the ROC curve for
the algorithm based on normalized blue MFI, excluding
melanosis from the analysis. The operating point indi-
cated on the ROC curve corresponds to a sensitivity of
92% and a specificity of 84%; the threshold values corre-
sponding to this operating point is a normalized blue MFI
of 0.86, which is indicated by the solid horizontal line in
Figure 3a.
Figure 3c shows a scatter plot of the normalized ratio of
red to green MFI by consensus clinical impression for all
sites. Sites with a consensus clinical impression of 'Low
Risk', 'High Risk' or 'Cancer' exhibit an increased normal-
ized red to green MFI ratio compared to 'Normal' sites;
on average, the normalized red to green MFI ratio
increases as the severity of the consensus clinical impres-
sion increases from 'Low Risk' to 'Cancer'. Sites with mel-
anosis show an increased normalized red to green MFI
ratio, while those with OSF have a similar normalized red
to green MFI ratio as other 'Normal' sites. Figure 3d
shows the ROC curve for the classification algorithm
based on the normalized red to green MFI ratio, exclud-
ing melanosis from the analysis. The operating point
indicated on the ROC curve corresponds to a sensitivity
of 90% and a specificity of 87% relative to the gold stan-
dard of consensus clinical impression. The threshold
value corresponding to this operating point is a normal-
ized red to green MFI ratio of 1.11, and is indicated by the
solid horizontal line shown in Figure 3c.
Discussion
This pilot study demonstrates that objective analysis of
fluorescence images obtained with a low-cost imaging
system can classify sites as neoplastic or non-neoplastic
with high sensitivity and specificity relative to the gold
standard of consensus clinical impression. The perfor-
mance of this low-cost, objective system compares favor-
ably to results reported for pilot studies of other optical
imaging systems. A recent review by De Veld summarizes
several clinical studies of optical imaging with qualitative
image analysis for detection of oral neoplasia and reports
sensitivity ranging from 63% to 100% and specificity from
79% to 96% [14]. More recently, Lane et al. achieved a
sensitivity of 98% and specificity of 100% using qualitative
assessment of fluorescence images acquired with the
VELScope to discriminate dysplasia and cancer from nor-
mal oral mucosa [5]. Roblyer reported quantitative analy-
sis of fluorescence and reflectance images obtained with a
multi-spectral digital microscope to classify oral prema-
lignant lesions and oral cancer with a sensitivity of 94%
and specificity of 87% [12]. Our results, obtained in a
South Asian population using the low-cost, portable opti-
cal imaging system described here, demonstrate similar
sensitivity and specificity.
Table 1: Consensus Clinical Impression of Measured Sites
Consensus Clinical Impression
Normal Low Risk for 
Neoplasia
High Risk for 
Neoplasia
Cancer
Melanosis or OSF Not 
Visible
222 30 22 37
Visible Melanosis 8 22 0 0
Visible OSF 2 8 0 0
Total 232 60 22 37
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based adjunctive techniques for oral cancer detection
have been carried out in high prevalence populations,
and recent reviews stress the need for randomized con-
trolled studies in low prevalence populations [15,16]. To
be useful in low resource settings where the vast majority
of oral cancers occur, screening aids must be affordable
and must not rely on significant clinical expertise for
image interpretation. Our results demonstrate the feasi-
bility of conducting these much needed trials using low-
cost, portable imaging devices in low resource settings.
The optical characteristics of oral lesions found in this
South Asian population are similar to those in other stud-
ies. Our finding of decreased fluorescence associated
with neoplastic lesions is consistent with reports in the
literature. This loss of autofluorescence has been attrib-
uted to a decrease in collagen cross-links associated with
neoplastic transformation [17]. Our results also indicate a
relative increase in red fluorescence for neoplastic sites.
Other studies have made similar observations, attributing
this increased red fluorescence to porphyrins [8,9,17].
In addition, we found the normalized red to green MFI
ratio to be amongst the top three best-performing fea-
tures. Roblyer also reported that this parameter was the
best performing feature for quantitative identification of
oral premalignant lesions and oral cancer using a multi-
spectral digital microscope [12]. Figure 4 presents the
normalized red to green MFI ratio for 57 sites in 21
patients measured by Roblyer at 450-nm excitation;
results are similar to those measured in this study (Figure
3c). Although the two studies were conducted indepen-
dently on two entirely different populations and using
two different instruments, the threshold ratio values from
the two different systems, nevertheless, were very similar.
The threshold to differentiate neoplastic sites from non-
neoplastic sites is in good agreement between the two
studies; here we found a threshold of 1.11 was optimal to
Figure 1 Images of lesions typical of the four consensus clinical 
impression categories. White light images are shown on the left and 
fluorescence images on the right. The top row illustrates 'Normal' buc-
cal mucosa, illustrating homogenous green fluorescence. The second 
row shows a site with a 'Low Risk' lesion of the buccal mucosa, with loss 
of fluorescence. The third row shows a site with a 'High Risk' lesion in 
the buccal mucosa with loss of fluorescence. Bottom row illustrates 
'Cancer' of the tongue, illustrating loss of green fluorescence and pres-
ence of orange-red fluorescence. Lesions are outlined in the image.
Figure 2 White light images (left column) and fluorescence imag-
es (right column) of typical lesions with OSF (top row) and mel-
anosis (bottom row). Areas with OSF show slightly increased green 
fluorescence. Melanosis is easily recognizable from the dark pigmenta-
tion in the white light image, and is associated with loss of fluores-
cence.
Table 2: Area Under the ROC Curve (AUC) of Top Five Image 
Features for Binary Classification of Oral Sites
Features AUC
Normalized MFI Green 
channel
0.91
Normalized MFI Blue channel 0.91
Normalized MFI Red/Green 
channel ratio
0.90
Normalized MFI Grayscale 0.89
Normalized MFI Red channel 0.85
MFI: Mean Fluorescence Intensity
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and Roblyer found a threshold of 1.09 could differentiate
premalignant lesions and cancers from normal tissue.
The ability of fluorescence-based screening aids to dif-
ferentiate precancerous lesions from benign lesions such
as inflammation must also be validated in larger trials and
the optical properties of other potentially confounding
lesions, which may be population specific, must be char-
acterized. For example, betel quid use is common in
south Asia and is associated with a high incidence of
OPLs as well as other potentially confounding oral
lesions, including melanosis and oral submucous fibrosis
(OSF) [18,19]. A recent study of 130 patients in the
United States noted that 72% of lesions clinically charac-
terized by inflammation or pigmentation show loss of flu-
oresecence with VELscope examination [20].
We characterized the optical properties of two types of
potentially confounding lesions, melanosis and OSF, spe-
cific to the geographic region. Melanosis is usually benign
and not considered to be precancerous [19]. Our results
indicate that sites with melanosis exhibit decreased fluo-
rescence, but can easily be recognized by their character-
Figure 3 Scatter plots of the image features and corresponding ROC curves for classification algorithms. (a) Scatter plot of the normalized 
blue MFI for all sites measured by consensus clinical impression. (b) ROC curve for diagnostic algorithm based on normalized blue MFI to differentiate 
between non-neoplastic sites (Normal, LR and OSF) and neoplastic sites (HR and Cancer). Measurements with melanosis were excluded from algo-
rithm development and testing. The open circle on the ROC curve indicates the Q-point. (c) Scatter plot of the normalized ratio of red to green MFI 
for all sites measured by consensus clinical impression. (d) ROC curve for diagnostic algorithm based on normalized ratio of red to green MFI to dif-
ferentiate between non-neoplastic sites (Normal, LR and OSF) and neoplastic sites (HR and Cancer). Measurements with melanosis were excluded 
from algorithm development and testing. The open circle on the ROC curve indicates the Q-point.
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loss of autofluorescence in melanosis is likely due to
strong absorption of light by black pigmentation in the
superficial epithelium. In contrast to melanosis, the
malignant transformation rate of OSF has been estimated
to be between 3% and 19% [21]. Most of the OSF sites
measured in this study were graded as 'Low Risk'. We
found that the OSF sites imaged here did not exhibit loss
of fluorescence. Histologically, OSF is characterized by
juxtaepithelial fibrosis, along with atrophy or hyperplasia
of the overlying epithelium, keratinizing metaplasia, and
accumulation of hyalinized collagen beneath the base-
ment membrane [22-24]. All of these constituents are
strong sources of autofluorescence and may contribute to
autofluorescence observed in our images of OSF sites.
The role of combined reflectance and fluorescence imag-
ing with quantitative image analysis for better discrimina-
tion of inflammation and neoplasia should be further
explored.
While the sensitivity and specificity reported here are
encouraging, there are a number of limitations of this
study. First, the same dataset was used both to develop
classification algorithms and to assess their performance;
in this situation, potential over-training can inflate esti-
mates of sensitivity and specificity. Results must be veri-
fied in an independent validation set. Second, the gold
standard used to assess algorithm performance was con-
sensus clinical impression; due to resource limitations,
histopathologic diagnosis was not available from all sites.
Finally, a large number of 'Low Risk' sites were misclassi-
fied as neoplastic by the optical algorithms presented
here. It is interesting to note that 'Low Risk' sites with
consensus among all three expert observers were more
likely to be classified by the optical algorithms as non-
neoplastic (6/10 = 60%) than were 'Low Risk' sites where
only two of the expert observers agreed (13/30 = 43%).
Additional studies with histologic endpoints for all sites
are required to assess the ability of quantitative optical
image analysis to aid in the evaluation of low risk oral
lesions.
Conclusions
The clinical study presented here demonstrates the ability
to identify neoplastic and non-neoplastic oral tissue in
vivo objectively using the low-cost, portable imaging sys-
tem. Although further work is needed to address the lim-
itations in this study, results from this pilot study suggest
that this simple imaging device can potentially improve
oral screening efforts in low-resource settings where clin-
ical expertise and resources are often limited.
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